A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers
Clinical trial NCT05392127 · COMPLETED
Trial details
- NCT number
- NCT05392127
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-15
- Primary completion
- 2022-08-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.